Skip to search formSkip to main contentSkip to account menu

Dexfenfluramine

Known as: Dexfenfluramine [Chemical/Ingredient], Dexfenfluraminum, (S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine 
The S-isomer of FENFLURAMINE. It is a serotonin agonist and is used as an anorectic. Unlike fenfluramine, it does not possess any catecholamine… 
National Institutes of Health

Related topics

Related topics

15 relations
Dexfenfluramine HydrochlorideDrug AllergyFenfluramineIn Blood

Narrower (2)

IsomerideRedux

Broader (1)

Serotonin Agonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Ghrelin at the interface of obesity and reward.
Highly Cited
2010
Highly Cited
2010
Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure
BACKGROUND AND PURPOSE The tail of the ventral tegmental area (tVTA), also called the rostromedial tegmental nucleus, is a newly… 
Review
2004
Review
2004
Prescription weight loss pill use among Americans: patterns of pill use and lessons learned from the fen-phen market withdrawal.
2002
2002
Dexfenfluramine protects against pulmonary hypertension in rats.
Dexfenfluramine (Dex), an appetite suppressant and serotonin reuptake inhibitor, is associated with pulmonary vascular disease… 
2002
2002
Saccadic peak velocity and EEG as end‐points for a serotonergic challenge test
We previously reported that a single dose of the serotonin receptor agonist meta‐chlorophenylpiperazine increased the peak… 
Review
1999
Review
1999
Obesity drugs and the heart.
Review
1998
Review
1998
Modern medical management of obesity: the role of pharmaceutical intervention.
1996
1996
Peripherally and centrally administered bombesin induce Fos-like immunoreactivity in different brain regions in rats
Review
1995
Review
1995
Clinical studies with dexfenfluramine: from past to future.
d Fenfluramine (dF) (15 mg twice daily) has been studied in controlled trials in human obesity. It has been shown to increase… 
Highly Cited
1990
Highly Cited
1990
Reversal of the anorectic effect of (+)‐fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK‐329
1 Experiments were conducted to determine whether or not the effect of (+)‐fenfluramine (3.0 mg kg−1, i.p.) on food intake can be… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)